Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT
Clinical trial NCT06482801 · RECRUITING
Trial details
- NCT number
- NCT06482801
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-10
- Primary completion
- 2030-12-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.